Trial Profile
Maintenance treatment with pemetrexed in patients with advanced non squamous non-small cell lung cancer in Algeria
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2014
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Apr 2014 New trial record